全文获取类型
收费全文 | 176544篇 |
免费 | 3534篇 |
国内免费 | 1660篇 |
专业分类
耳鼻咽喉 | 1879篇 |
儿科学 | 7229篇 |
妇产科学 | 2815篇 |
基础医学 | 20821篇 |
口腔科学 | 4349篇 |
临床医学 | 12780篇 |
内科学 | 33556篇 |
皮肤病学 | 2986篇 |
神经病学 | 10429篇 |
特种医学 | 3524篇 |
外国民族医学 | 1篇 |
外科学 | 26996篇 |
综合类 | 11066篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 10477篇 |
眼科学 | 3321篇 |
药学 | 18419篇 |
17篇 | |
中国医学 | 6264篇 |
肿瘤学 | 4804篇 |
出版年
2022年 | 1524篇 |
2021年 | 2669篇 |
2020年 | 1440篇 |
2019年 | 13111篇 |
2018年 | 12704篇 |
2017年 | 5756篇 |
2016年 | 1375篇 |
2015年 | 1353篇 |
2014年 | 3378篇 |
2013年 | 5038篇 |
2012年 | 3378篇 |
2011年 | 3505篇 |
2010年 | 2920篇 |
2009年 | 2895篇 |
2008年 | 3367篇 |
2007年 | 4392篇 |
2006年 | 4564篇 |
2005年 | 4423篇 |
2004年 | 3462篇 |
2003年 | 3468篇 |
2002年 | 3263篇 |
2001年 | 3243篇 |
2000年 | 3468篇 |
1999年 | 3160篇 |
1998年 | 3186篇 |
1997年 | 2527篇 |
1996年 | 2352篇 |
1995年 | 2700篇 |
1994年 | 2532篇 |
1993年 | 1969篇 |
1992年 | 1559篇 |
1991年 | 1548篇 |
1990年 | 1297篇 |
1989年 | 1045篇 |
1988年 | 1075篇 |
1987年 | 1027篇 |
1986年 | 870篇 |
1985年 | 5433篇 |
1984年 | 7302篇 |
1983年 | 5838篇 |
1982年 | 6294篇 |
1981年 | 5725篇 |
1980年 | 4923篇 |
1979年 | 5004篇 |
1978年 | 4084篇 |
1977年 | 3080篇 |
1976年 | 3542篇 |
1975年 | 2745篇 |
1974年 | 2532篇 |
1973年 | 2244篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Phenotypic and genetic features of enteropathogenic Escherichia coli isolates from diarrheal children in the Ribeirão Preto metropolitan area,São Paulo State,Brazil 下载免费PDF全文
André Pitondo‐Silva Gerson Nakazato Juliana P. Falcão Kinue Irino Roberto Martinez Ana Lúcia C. Darini Rodrigo Tavanelli Hernandes 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2015,123(2):128-135
This study was designed to characterize a collection of 60 enteropathogenic Escherichia coli (EPEC) isolates from diarrheic feces of patients in the Ribeirão Preto metropolitan area regarding different phenotypic and molecular features. We examined antibiotic resistance profiles, occurrence of virulence factors‐encoding genes, intimin subtypes and the correlation of serotypes among typical (tEPEC) and atypical (aEPEC) EPEC isolates. The results demonstrated that atypical EPEC was more heterogeneous than typical EPEC concerning the characteristics investigated and 45.2% do not belong to classical EPEC serogroups. Intimin subtype β was the most frequent among the EPEC isolates (46.7%), being detected in both tEPEC and aEPEC. The majority of aEPEC isolates presented localized adherence‐like (LAL) pattern to HEp‐2 cells, although aEPEC isolates displaying diffuse adherence (DA) or non‐adherent were also detected. High prevalence of antimicrobial resistance was found for ampicillin, cephalothin, sulfonamide and tetracycline. In general, tEPEC isolates were more resistant to the antimicrobials tested than aEPEC isolates. 相似文献
102.
103.
《Vaccine》2016,34(24):2663-2670
Human metapneumovirus (HMPV) is a major cause of morbidity and mortality from acute lower respiratory tract illness, with most individuals seropositive by age five. Despite the presence of neutralizing antibodies, secondary infections are common and can be severe in young, elderly, and immunocompromised persons. Preclinical vaccine studies for HMPV have suggested a need for a balanced antibody and T cell immune response to enhance protection and avoid lung immunopathology. We infected transgenic mice expressing human HLA-A*0201 with HMPV and used ELISPOT to screen overlapping and predicted epitope peptides. We identified six novel HLA-A2 restricted CD8+ T cell (TCD8) epitopes, with M39–47 (M39) immunodominant. Tetramer staining detected M39-specific TCD8 in lungs and spleen of HMPV-immune mice. Immunization with adjuvant-formulated M39 peptide reduced lung virus titers upon challenge. Finally, we show that TCD8 from HLA-A*0201 positive humans recognize M39 by IFNγ ELISPOT and tetramer staining. These results will facilitate HMPV vaccine development and human studies. 相似文献
104.
105.
106.
107.
108.
《Journal of the American Medical Directors Association》2020,21(3):439.e9-439.e13
Background/ObjectivesPolypharmacy and multimorbidity is a threat to older people; hence, listing approaches should support physicians to optimize medication. The FORTA (Fit fOR The Aged) classification of drug appropriateness for older people provides positive or negative labels: A (A-bsolutely), B (B-eneficial), C (C-areful), and D (D-on't). Based on these categories, FORTA-labeled drug lists were developed in 7 European countries or regions; the same approach was used to develop a U.S.-FORTA List reflecting the country-specific availability and usage of drugs.Design/SettingA 2-step Delphi-type approach was employed to add, remove, or relabel drugs from the listing proposal and to add or remove new indications. The proposal utilized the European (EURO)-FORTA list as template.ParticipantsEight US-based geriatricians/pharmacists served as raters. Measurements: Raters gave recommendations and comments on the list items.ResultsThe first U.S.-FORTA List contains 273 items aligned to 27 main indication groups; 30 drugs and drug groups were added, and 23 removed as being unavailable in the United States. The highest percentage of changes in FORTA labels as compared to the EURO-FORTA List occurred for sleep disorders associated with dementia (40%). In 8 indications, the labels for 11 items were different from the proposal. Thus, for the majority of the items (n = 232, 95.5%), the proposals were accepted by the US raters. Only 16 (6.6%) of the proposed items (n = 243) had to be re-evaluated in the second round as a result of inconsistent rating in the first round.Conclusions and ImplicationsThe U.S.-FORTA List addresses the appropriateness of drugs for older people in the United States reflecting country-specific availability, usage, and expert rating. As shown for the FORTA list in Europe, this listing approach is among the few that are clinically validated and improve well-being and geriatric outcomes. The U.S.-FORTA List now largely enhances the global availability of this approach. 相似文献
109.
I. Fouzas C. Papanikolaou G. Katsanos N. Antoniadis N. Salveridis K. Karakasi S. Vasileiadou A. Fouza E. Mouloudi G. Imvrios V. Papanikolaou 《Transplantation proceedings》2019,51(2):416-420
Aims
Variations of the anatomy of donor hepatic arteries increase the number of arterial anastomoses during liver transplantation and, possibly, the incidence of hepatic artery thrombosis (HAT). In this study, we describe the arterial anatomic variations in liver grafts procured and transplanted by a single center in Greece, the techniques of arterial anastomosis, and their effect on the incidence of early HAT.Materials and Methods
From January 2013 to December 2017, the arterial anatomy of 116 grafts procured for liver transplantation were recorded, as well as the technique of arterial anastomosis and the incidence of early hepatic artery thrombosis (HAT <30 days).Results
A single hepatic artery was recorded in 72.41% of the procured grafts, an aberrant left hepatic artery (accessory or replaced) in 18 grafts (15.52%), and an aberrant right hepatic artery (accessory or replaced) in 17 grafts (14.66%), while other variations were observed in less than 1% of the procured livers. Of the 116 primary liver transplantations, 6 patients (5.17%) developed early HAT <30 days. Two of these patients (1.72%) had 1 anastomosis of the hepatic artery and 4 (3.45%) had 2 anastomoses due to anatomic variations.Conclusions
Anatomic variations of the hepatic artery in liver grafts is a common finding and increase the incidence of early HAT but not to a degree to make these grafts unusable. 相似文献110.